Safe therapeutics of murine melanoma model using a novel antineoplasic, the partially methylated mannogalactan from Pleurotus eryngii (2017)
- Authors:
- Autor USP: CHAMMAS, ROGER - FM
- Unidade: FM
- DOI: 10.1016/j.carbpol.2017.08.117
- Subjects: MELANOMA; ANTINEOPLÁSICOS; TERAPÊUTICA; COGUMELOS COMESTÍVEIS
- Language: Inglês
- Imprenta:
- Source:
- Título: Carbohydrate Polymers
- ISSN: 0144-8617
- Volume/Número/Paginação/Ano: v. 178, p. 95-104, 2017
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
BISCAIA, Stellee Marcela Petris et al. Safe therapeutics of murine melanoma model using a novel antineoplasic, the partially methylated mannogalactan from Pleurotus eryngii. Carbohydrate Polymers, v. 178, p. 95-104, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.carbpol.2017.08.117. Acesso em: 06 maio 2026. -
APA
Biscaia, S. M. P., Carbonero, E. R., Bellan, D. L., Borges, B. S., Costa, C. R., Rossi, G. R., et al. (2017). Safe therapeutics of murine melanoma model using a novel antineoplasic, the partially methylated mannogalactan from Pleurotus eryngii. Carbohydrate Polymers, 178, 95-104. doi:10.1016/j.carbpol.2017.08.117 -
NLM
Biscaia SMP, Carbonero ER, Bellan DL, Borges BS, Costa CR, Rossi GR, Gonçalves JP, Melo CM, Lívero FAR, Ruthes AC, Zotz R, Silva EV, Oliveira CC, Acco A, Nader HB, Chammas R, Iacomini M, Franco CRC, Trindade ES. Safe therapeutics of murine melanoma model using a novel antineoplasic, the partially methylated mannogalactan from Pleurotus eryngii [Internet]. Carbohydrate Polymers. 2017 ; 178 95-104.[citado 2026 maio 06 ] Available from: https://doi.org/10.1016/j.carbpol.2017.08.117 -
Vancouver
Biscaia SMP, Carbonero ER, Bellan DL, Borges BS, Costa CR, Rossi GR, Gonçalves JP, Melo CM, Lívero FAR, Ruthes AC, Zotz R, Silva EV, Oliveira CC, Acco A, Nader HB, Chammas R, Iacomini M, Franco CRC, Trindade ES. Safe therapeutics of murine melanoma model using a novel antineoplasic, the partially methylated mannogalactan from Pleurotus eryngii [Internet]. Carbohydrate Polymers. 2017 ; 178 95-104.[citado 2026 maio 06 ] Available from: https://doi.org/10.1016/j.carbpol.2017.08.117 - Bradykinin-dependent pathways are activated within tumor microenvironments new targets for therapy
- Hedgehog signaling pathway mediates tongue tumorigenesis in wild-type mice but non Gal3: Deficient mice
- Use of RNA interference to investigate ADAM23 function and its role breast cancer progression
- F-18-Fluoride PET/CT and Tc-99m-MDP SPECT/CT can detect bone cancer at early stage in rodents
- Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications
- Bases da biologia molecular
- ADAM23 silencing in breast cancer is associated with capase-1 and DAPK-1 downregulation and resistance to anoikis
- Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice
- Epigenetic mechanisms control galectin-3 gene expression along murine melanoma progression
- Lack of galectin-3 modifies differentially Notch ligands in bone marrow and spleen stromal cells interfering with B cell differentiation
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
